Keros Therapeutics (KROS) Return on Sales: 2019-2025
Historic Return on Sales for Keros Therapeutics (KROS) over the last 3 years, with Sep 2025 value amounting to 0.26%.
- Keros Therapeutics' Return on Sales rose 28871.00% to 0.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.26%, marking a year-over-year increase of 28871.00%. This contributed to the annual value of -52.78% for FY2024, which is N/A change from last year.
- Latest data reveals that Keros Therapeutics reported Return on Sales of 0.26% as of Q3 2025, which was up 224.00% from 0.08% recorded in Q2 2025.
- In the past 5 years, Keros Therapeutics' Return on Sales ranged from a high of 0.26% in Q3 2025 and a low of -657.22% during Q2 2024.
- In the last 3 years, Keros Therapeutics' Return on Sales had a median value of -4.45% in 2023 and averaged -112.90%.
- In the last 5 years, Keros Therapeutics' Return on Sales tumbled by 28,442bps in 2024 and then soared by 65,730bps in 2025.
- Over the past 5 years, Keros Therapeutics' Return on Sales (Quarterly) stood at -2.94% in 2021, then reached -1.76% in 2022, then reached -4.45% in 2023, then slumped by 4,832bps to -52.78% in 2024, then soared by 28,871bps to 0.26% in 2025.
- Its last three reported values are 0.26% in Q3 2025, 0.08% for Q2 2025, and 0.02% during Q1 2025.